Biohaven Pharmaceutical
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -960 | -1,105 | -1,014 | |
EBITDA | -142,631 | -172,117 | -209,723 | -219,315 |
EBIT | -145,204 | -173,222 | -211,701 | -221,561 |
Net Income | -145,555 | -173,443 | -198,147 | -221,677 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -130,670 | -145,729 | -168,169 | -165,585 |
Cash | 229,957 | 184,847 | 165,797 | 98,417 |
Basic Shares | 120,187 | 105,815 | 102,372 | 101,943 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -4,139 | -3,923 | -3,369 | -1,386 |
EBITDA | -727,458 | -877,256 | -429,139 | -566,546 |
EBIT | -737,380 | -885,111 | -436,051 | -567,932 |
Net Income | -738,822 | -846,422 | -408,168 | -570,279 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -610,153 | -586,502 | -334,773 | -338,763 |
Cash | 229,957 | 99,134 | 248,402 | 204,877 |
Basic Shares | 107,624 | 91,234 | 71,201 | 44,741 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.90 |
2025-09-30 | -$1.64 |
2025-06-30 | -$1.94 |
